Target intelligence / Profile preview

Ribosomal protein L23a pseudogene 56 (RPL23AP56)

Target
RPL23AP56
Molecular classification
Other (Processed pseudogene)
01

Overview

Ribosomal protein L23a pseudogene 56 (RPL23AP56) is one of many pseudogenes related to the ribosomal protein L23a (RPL23A) gene. Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional—they do not encode active protein products. RPL23AP56 is annotated as a processed pseudogene without known protein-coding capacity or direct biological activity. The functional ribosomal protein L23a (RPL23A) is a structural component of the 60S ribosomal subunit with roles in ribosome assembly and possibly immune responses, but its pseudogenes—including RPL23AP56—do not carry out these functions. Conservation across species hints at possible undiscovered regulatory roles in rare cases, but currently, there is no evidence that RPL23AP56 itself represents a druggable target, disease biomarker, or participant in therapeutic strategies. This entry is thus not considered a therapeutic target and the name is most accurately described as a pseudogene, not a receptor, enzyme, or functional molecule.

Other names
RPL23A_21_952RPL23AP56

Beyond the preview

Go deeper on Ribosomal protein L23a pseudogene 56 (RPL23AP56).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L23a pseudogene 56 (RPL23AP56).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call